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INTRODUCTION 
The cell cycle encompasses all morphological and biochemical events that occur during 
the lifetime of a cell, including metabolism, growth and division. Progression through the 
cell cycle is regulated by internal clocks that control passage through multiple 
checkpoints. External stimuli also affect cell cycle progression. In vivo, stimulation from 
the cellular environment, mediated by hormones or neighboring cells, can promote or 
slow down cell division, and cause differentiation or cell death. Thus, cells need to 
establish a complex network of signaling pathways that register and process external cues 
in the context of their own internal clocks.  
Transduction of an extracellular signal to intracellular effectors involves cascade 
of signaling events. This cascade includes the stimulation of surface receptor ligands on 
the target cell and transfer of the external signal to the cell interior. Intracellular second 
messengers propagate the signal to effector molecules, which in turn carry out the 
internal response to the external stimuli. Protein kinases and phosphatases are two major 
classes of effector proteins which alter the behavior of specific target proteins by 
phosphorylation and dephosphorylation, respectively. The phosphorylation status of 
many proteins contributes to define their localization, (substrate) binding properties or 
enzymatic activity. Protein phosphorylation and dephosphorylation are therefore involved 
in a wide range of cellular processes. Furthermore, as the level of protein phosphorylation 
can also act as a cellular signal, regulation and specificity of protein kinases and 
phosphatases become extremely important. Results presented in this thesis provide new 
biochemical and functional insights into two such phospho-regulating proteins involved 
in cell cycle progression, nucleic acid binding and mitochondrial distribution. 
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1. The cell cycle 
Progression through the cell cycle 
The eukaryotic cell cycle is typically divided into four phases, namely G1, S, G2 and M-
phase. G1 is the phase when cells prepare to synthesize a duplicate copy of DNA. Cells in 
G1 can either exit the cell cycle G0 and quiesce, or progress into S phase and replicate 
their DNA. Cells about to enter G0 repress genes needed for entry into mitosis such as 
cyclins and cyclin-dependent kinases (Cdks); consequently, the cell leaves the cell cycle 
temporarily or permanently. Some cell types in mature organisms, such as parenchymal 
cells of the liver and kidney, enter G0 semi-permanently and only start dividing again 
under specific circumstances (Jirtle et al., 1981). Other cell types, such as epithelial cells, 
continue to divide throughout an organism's life (Stampfer et al., 1993). M-phase is 
comprised of mitotic chromosome division and cytokinesis (Fig. 1). The purpose of 
mitosis is to enable successful and equal transmission of the genetic material into two 
daughter cells.  
 
 
Figure 1. Stages of mitosis in a mammalian cell. In prophase (a) chromatin condenses into chromosomes, 
the nuclear envelope breaks down and the nucleolus disappears. In metaphase (b) chromosomes are aligned 
on the equatorial plane by the microtubuli attached to the centromeres. The two sister chromatids are 
attached to kinetochore microtubuli originating from the centrosomes at opposite ends of the cell. In 
anaphase (c) the two sister chromatids break apart and daughter chromosomes move towards opposite 
spindle poles. In telophase (d) the chromosomes decondense and the new nuclear envelope reforms (taken 
from www.sirinet.net/~jgjohnso/biologyI.html).  
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Regulation of Mitosis  
Mitosis is primarily regulated by phosphorylation and proteolysis. The two are 
interrelated, as phosphorylation can regulate the proteolytic machinery, and mitotic 
kinases can be down-regulated by proteolysis (Peters, 2002). 
 Cdks are central components that coordinate cell-division. Mitotic cyclin-Cdk 
complexes drive events of early mitosis like chromosome condensation, nuclear envelope 
(NE) breakdown, and assembly of the mitotic spindle. Cdks complete their main 
functions by metaphase, when sister chromatid pairs are bi-oriented on the spindle, but 
held together by sister-chromatid cohesion (Sullivan and Morgan, 2007). In presumably 
all eukaryotes, sister chromatid separation and anaphase entry follow cyclin ubiquitin-
dependent proteolysis to inactivate Cdk1 (Glotzer et al., 1991). This event is mediated by 
the anaphase promoting complex (APC), a cell cycle-regulated ubiquitin ligase that 
assembles multi-ubiquitin chains on regulatory proteins such as securins and cyclins and 
thereby targets them for destruction (Glotzer et al., 1991).  
 Entry into mitosis is characterized by a global increase in protein phosphorylation. 
Phosphorylation of several nuclear membranes, lamin and chromatin proteins correlates 
with dissociation of the NE from chromosomes (Courvalin et al., 1992; Foisner and 
Gerace, 1993; Collas and Courvalin, 2000). Among DNA- and chromosome-associated 
proteins, histones H1, H2B, H3 and H4 are phosphorylated at mitosis entry (Dimitrov and 
Wolffe, 1996; Hsu et al., 2000; Speliotes et al., 2000; Murnion et al., 2001; Giet and 
Glover, 2001; Barber et al., 2004). The role of histone phosphorylation in chromosome 
condensation is unclear, but three models have been proposed. 
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 One model hypothesizes that addition/removal of a phosphate group alters the 
charge of the nucleosome, which in turn affects intra- or inter-nucleosomal structure and 
stability. Such alterations could potentially facilitate chromatin condensation and/or sister 
chromatid separation (Prigent and Dimitrov, 2003). A second model hypothesizes that 
mitotic histone phosphorylation may directly contribute to the resolution of sister 
chromatids, possibly by enhancing flexibility of the chromatin fibers (Murnion et al., 
2001) or by increasing electrostatic repulsion between the two chromatids (Swedlow and 
Hirano, 2003). This in turn contributes to chromatin condensation and sister chromatid 
separation (Swedlow et al., 2003). In the third model, histones serve as docking sites for 
effector proteins that mediate chromatin condensation and separation (Kanno et al., 
2004). This illustrates the importance of histone modifications in signal transduction 
cascades and in mediating protein binding to chromatin (Fischle et al., 2003; Kanno et 
al., 2004). 
 NE breakdown and lamin phosphorylation resulting in lamin depolymerization is 
another important regulatory event in mitosis. In vertebrates, NE disassembly defines the 
transition between prophase and prometaphase (Foisner, 2003). Lamin depolymerization 
is important for the dissociation of proteins from chromatin and normal NE breakdown. 
Accordingly, cells expressing lamin mutants that can not be phosphorylated by mitotic 
kinases do not efficiently disassemble the NE (Foisner, 2003). 
 Numerous other proteins are known to regulate entry into mitosis, and several 
have been shown to be important or necessary for proper cell progression through 
mitosis. For instance, Aurora B contributes to chromosome condensation by 
phosphorylating H3 and by regulating the condensin complex (See page 14) (Takemoto 
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et al., 2007). In Schizosaccharomyces pombe (S. pombe), Caenorhabditis elegans (C. 
elegans) and Drosophila melanogaster (D.melanogaster), condensins fail to associate 
with chromatin in metaphase if phosphorylation by Aurora B is inhibited (Giet et al., 
2001; Petersen et al., 2001; Kaitna et al., 2002). Furthermore, phosphorylations of the 
Never in Mitosis Gene A (NIMA) family of proteins by Cdk1 and of polo kinases family 
(e.g., polo-like kinase 1 or plk1) by an unidentified kinase, are essential for mitosis entry 
(Ferrari, 2006).  
 Conversely, protein dephosphorylation is required for chromatin decondensation 
and reentry into interphase. This includes H3 dephosphorylation by protein phosphatase 1 
(PP1) (Murnion et al., 2001). An emerging concept is that precise ordering of late mitosis 
events depends, at least in part, on the order in which Cdk substrates are 
dephosphorylated and APC targets are destroyed (Sullivan et al., 2007). Thus, the 
reversible phosphorylation of chromatin-associated proteins through mitosis is 
widespread, essential and complex.  
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Mitotic chromosome condensation 
Upon entry into mitosis, chromosomes undergo reversible condensation. Human mitotic 
chromosomes are compacted 15 000-20 000-fold, as defined by the ratio of DNA to 
chromosome length (Li et al., 1998). This massive compaction is essential to ensure 
correct transmission of genetic information during cell division. A component essential 
for proper progression through mitosis is topoisomerase II (Uemura et al., 1987;Adachi et 
al., 1991; Saka et al., 1994; Saitoh et al., 1995). Topoisomerase II is postulated to be 
involved in DNA supercoiling, individualization of chromosomes (Gimenez-Abian et al., 
1995; Losada et al., 2002) and separation of sister chromatids in anaphase (Uemura and 
Yanagida, 1984; Holm et al., 1985; Shamu and Murray, 1992). A family of adenosine 
triphosphatases (ATPases), called structural maintenance of chromosome (SMC) 
proteins, is also essential for normal progression through mitosis (Hirano, 1999; Hirano, 
2002). SMC protein complexes are conserved from yeast to mammals and were first 
identified in Saccharomyces cerevisiae (S. cerevisiae) (Strunnikov et al., 1993; 
Strunnikov et al., 1995). There are two known SMC protein complexes that each consist 
of two SMC and three non-SMC subunits (Fig. 2). SMCs are involved in sister-chromatid 
cohesion, chromosome assembly, DNA recombination and repair and gene dosage 
compensation (Hagstrom and Meyer, 2003)                                                
 
Figure 2. Composition of condensin I and II remodeling 
complexes. Condensin I and II contain the same SMC subunits 
but different non-SMC subunits (Losada and Hirano, 2005). 
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The exact structure and formation of mitotic chromosomes is not known, but at 
least two hypotheses exist. One hypothesis proposes DNA compaction around a protein 
backbone and has three main models (Fig. 3): 1) the helical folding model suggests 
helical coiling of the 30 nm chromatin fiber into progressively larger structures (Sedat 
and Manuelidis, 1978); 2) the radial loop model proposes that DNA is connected in loop 
domains to a protein scaffold (Paulson and Laemmli, 1977; Marsden and Laemmli, 
1979); 3) the combined radial loop-helical folding model suggests a combination of the 
two previous models (Rattner and Lin, 1985; Boy de la and Laemmli, 1988).  
The second hypothesis monitors changes in chromosome elasticity and 
deformability induced by nuclease digestion and physical stretching of individual 
chromosomes (Houchmandzadeh et al., 1997; Poirier et al., 2002a; Poirier and Marko, 
2002a; Poirier and Marko, 2002b; Poirier et al., 2002c). From force measurements and 
chromosome micromanipulation experiments, shape, structure and mechanical properties 
of chromosomes were shown to depend on the structural integrity of DNA, ruling out a 
primary structural role for a physically contiguous protein network embedded within the 
chromosome (Poirier et al., 2002b). However, these results do not rule out the possibility 
of a dynamic protein assembly that could drive chromatin folding into chromosomes of a 
defined shape (Jessberger, 2003). 
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Figure 3.Three models for chromosome structure and formation. The helical folding model suggests helical 
coiling of the 30 nm fiber into progressively larger structures (Sedat et al., 1978). The radial loop model 
proposes that DNA is connected in loop domains to a protein scaffold (Paulson et al., 1977;Marsden et al., 
1979). The combined radial loop-helical folding model suggests a combination of the two previous models 
(Rattner et al., 1985;Boy de la et al., 1988). Modified from home.planet.nl/~gkorthof/korthof59.htm. 
 
Most text book models of mitotic chromosome structure feature the radial loop 
model of mitotic chromosome condensation (Fig. 3) (Paulson et al., 1977). There are 
major questions regarding this model however, since the major identified components of 
the protein scaffold are topoisomerase II and SMC2. Neither topoisomerase II nor SMC2 
are obvious candidates as building blocks for a structural scaffold network as they do not 
form an axial chromosome staining pattern until late prophase, when chromosome 
compaction is nearly complete. Studies in mammals, chicken, C. elegans and D. 
melanogaster have led to the conclusion that compaction of chromatin and formation of a 
longitudinal chromosome axis proceeds in the absence of topoisomerase II or SMC2, 
albeit with serious sister chromatid separation and chromosome segregation defects 
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(Steffensen et al., 2001; Hagstrom et al., 2002; Coelho et al., 2003; Hudson et al., 2003; 
Hirota et al., 2004; Gassmann et al., 2004; Savvidou et al., 2005).  
 The radial loop model has recently been strengthened by the discovery of 
potential components of the mitotic chromosome scaffold. Based on salt and detergent 
extraction of chromatin, a list of 79 components of the chromosome scaffold fraction 
have been published (Gassmann et al., 2005), of which 30 have not previously been 
identified as components of mitotic chromosomes, and 15 are uncharacterized. 
Interestingly, two of the proteins identified, nuclear protein (P30) and human kinesin 
superfamily protein member 4A (HKIF4A) have previously been shown to be involved in 
proper chromosome condensation (Mazumdar et al., 2004; Gassmann et al., 2005). 
Furthermore, overexpression of P30 or HKIF4A knockdown leads to hypercondensed 
chromatin (Mazumdar et al., 2004; Gassmann et al., 2005). The incomplete picture 
concerning both chromatin condensation and maintenance of mitotic chromosomes imply 
the existence of another, as yet undiscovered molecular mechanism driving chromosome 
condensation. 
In vitro systems have been used to study chromosome condensation and 
decondensation. Xenopus laevis (X. laevis) pronulei or somatic nuclei incubated in a 
mitotic Ca2+-free X. laevis egg extract undergo NE breakdown, chromosome 
condensation and spindle formation in a calcium-dependent manner (Lohka and Masui, 
1984a; Lohka and Maller, 1985). On the contrary, chromosome decondensation can be 
observed after incubation of X. laevis sperm nuclei in calcium-activated extract (Lohka et 
al., 1984a). Further, it has been shown by us and others that in vitro chromosome 
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condensation and decondensation can take place in extracts from Hela cells (Wood and 
Earnshaw, 1990; Collas et al., 1999a; Steen et al., 2000a). 
These observations indicate that chromosome condensation and decondensation 
can be simulated in vitro using exogenous substrates in lysates from eggs or somatic 
cells. Work presented in this thesis (paper I) relies on an extract derived from interphase 
HeLa cells to indicate the role of a nuclear protein phosphatase regulator on 
decondensation of mitotic chromosomes. 
 
Chromosome decondensation 
Two major events of mitosis exit are chromosome decondensation and NE reassembly. 
Molecular events involved in mitotic chromosome decondensation remain largely 
unresolved, but as expected, many chromosome-related events that take place at mitosis 
entry are reversed at mitosis exit. Ran binding protein 1 (RanBP1) and regulator of 
chromosome condensation 1 (RCC1) are two components of the small GTPase Ran cycle 
which controls nuclear protein import and export, but which is also important in mitosis 
for spindle assembly and chromosome decondensation (Fig. 4) (Zhang et al., 2002; 
Quimby and Dasso, 2003; Clarke and Zhang, 2008). Ran mutants with deficient GTPase 
domain, or RCC1 mis-localization from chromosomes produces defects in chromosome 
alignment at metaphase or multipolar spindles (Zhang et al., 1999; Wilde and Zheng, 
1999; Ohba et al., 1999; Carazo-Salas et al., 1999). Moreover RCC1 depletion from X. 
laevis extracts or RanBP1 overexpression in mammalian cells leads to chromosome 
decondensation failure (Sazer and Nurse, 1994; Battistoni et al., 1997; Zhang et al., 
2002). Furthermore, direct binding of RCC1 to chromatin, followed by local generation 
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of Ran-GTP and GTP hydrolysis by Ran, induces chromatin decondensation, membrane 
vesicle recruitment to chromosomes, reformation of the NE and reassembly of nuclear 
pore complexes (Hetzer et al., 2000; Zhang and Clarke, 2000). Collectively, these 
observations imply an important role for RCC1 and Ran in the process of chromosome 
decondensation. 
 
 
Figure 4. RanGTP throughout the cell cycle (Taken from webpage of Mattaj Group, www-
db.embl.de/jss/EmblGroupsHD/g_45.html). During interphase Ran is located on both sides of the NE and 
actively drives transport through the nuclear pore complex. When the NE breaks down as the cell enters 
mitosis RanGTP is important for mitotic spindle assembly. Further as mitosis reaches anaphase RanGTP is 
essential to reform the nuclear pore complexes and the NE. 
 
 
Ubiquitination and degradation of mitotic cyclins at metaphase that inactivate Cdks, 
are another prerequisite for proper chromosome decondensation (Sullivan et al., 2007). 
This allows dephosphorylation of the many Cdk substrates necessary for normal 
chromosome and spindle movements in anaphase, and for spindle disassembly, 
reformation of NE and chromosome decondensation through telophase (Sullivan et al., 
2007). Cyclin oscillations through the cell cycle represent a good example of the essential 
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spatiotemporal regulation of protein phosphorylation and dephosphorylation to ensure 
proper cell division, differentiation and viability.  
 
2. Protein phosphorylation and dephosphorylation 
Intracellular signaling through cAMP-dependent protein kinase A 
Approximately one third of eukaryotic proteins are regulated by phosphorylation. Cyclic 
AMP (cAMP)-dependent protein kinase, or protein kinase A (PKA), is a central and well 
studied Serine/Threonine (Ser/Thr) protein kinase (Skalhegg and Tasken, 1997; Kim et 
al., 2006). The intracellular messenger cAMP regulates numerous biological processes 
including motility, metabolism, differentiation, immune function, insulin secretion and 
cardiac contraction (Meinkoth et al., 1993; Montminy, 1997; Diviani, 2008; Lafontan et 
al., 2008). Production of cAMP is primarily triggered by agonist-induced activation of 
transmembrane G protein-coupled receptors followed by activation of adenylyl cyclases 
at the inner side of the plasma membrane. cAMP activates a limited number of effectors 
including PKA which, by phosphorylating a multiplicity of nuclear and cytoplasmic 
targets, mediates numerous biological effects (Traish et al., 1997; Zaccolo et al., 2006; 
Chiaradonna et al., 2008). 
 The PKA holoenzyme is composed of two regulatory and two catalytic subunits. 
The different isoforms of the regulatory (RI, RI, RII, RII) and catalytic (C, C, C) 
subunits possess distinct physical and biological properties. They are differentially 
expressed and their combination creates different isoforms of PKA holoenzymes (Tasken 
and Aandahl, 2004; Kim et al., 2006). PKA type I holoenzyme consists of RI subunits 
and PKA type II holoenzymes contain RII subunits. Specificity of PKA is largely 
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determined by the structure and properties of the regulatory subunits, whereas the 
catalytic subunits exhibit similar kinetic features and substrate specificities (Kim et al., 
2006). Both PKA types I and II holoenzymes are activated by cAMP binding to the 
regulatory (R) subunit dimer. This releases the activated catalytic subunit to enable 
substrate phosphorylation (Vermeulen et al., 2003; Wong and Scott, 2004; Tasken et al., 
2004; Zaccolo et al., 2006). 
 Phosphodiesterases (PDEs) are the only known cyclic nucleotide-degrading 
enzymes and, therefore, are critical regulators of cAMP intracellular homeostasis by 
hydrolyzing cAMP to AMP (Houslay and Adams, 2003; Conti and Beavo, 2007). It has 
been reported that cells contains a large number of conserved PDEs, each of them with 
several isoforms, able to hydrolyze cAMP (Soderling and Beavo, 2000). Furthermore, 
isoform-specific knockdown in the PDE4 subfamily shows distinct phenotypes, 
indicating that the large PDE isoform diversity and numbers may control the cAMP pool 
in a spatio-temporal manner (Jin and Conti, 2002; Zaccolo and Movsesian, 2007). 
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AKAP’s: multiscaffoling proteins that anchor PKA 
Given the large diversity of PKA targets, precise regulation and confined activity in PKA 
signaling is essential for specificity of the intracellular response. A major family of 
proteins regulating PKA signaling consists of A kinase-anchoring proteins (AKAPs).  
 AKAPs are a structurally diverse family of functionally related proteins with 
more than 50 members including splice-variants. AKAPs are defined on the basis of their 
ability to bind radioactively labeled PKA regulatory subunits in overlay assays, and co-
precipitate PKA catalytic activity (Hausken and Scott, 1996; Wong et al., 2004; 
McConnachie et al., 2006). Their functional significance also involves targeting of the 
PKA holoenzyme to specific subcellular compartments to focus PKA activity towards 
relevant substrates. This, therefore, provides spatial and temporal regulation of PKA 
signaling (Colledge and Scott, 1999; Tasken et al., 2004; Langeberg and Scott, 2005). 
Anchored pools of PKA are selectively activated by pools of cAMP that are spatially 
regulated by the activity of PDEs (Tasken et al., 2004; Zaccolo et al., 2007). 
 AKAPs share at least three common features. 1) A conserved PKA binding motif 
that consists of a 14-20 amino-acids amphipatic helix able to interact with the amino-
terminus of the regulatory subunit dimer (Carr et al., 1992; Newlon et al., 1999; Newlon 
et al., 2001; Fayos et al., 2003; Taylor et al., 2005). 2) A unique targeting domain 
directing the AKAP-PKA complex to discrete subcellular sites including the plasma-
membrane, mitochondria, centrosomes, Golgi, endoplasmic reticulum (ER) and the 
nucleus (Fig. 5) (Feliciello et al., 2001; Wong et al., 2004). 3) Most AKAPs have the 
ability to form multivalent signal transduction complexes by interacting with additional 
binding partners and signaling molecules such as protein kinase C (PKC), PDEs, small 
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GTPases, PP1, protein phosphatase 2A (PP2A) or protein phosphatase 2B (PP2B) 
(Colledge et al., 1999; Diviani and Scott, 2001; Wong et al., 2004; Tasken et al., 2004; 
Diviani, 2008). Hence, the AKAP complexes have emerged as multi-scaffolding adaptor 
molecules with an essential role in the spatial and temporal integration of effectors and 
substrates. AKAPs provide a high level of specificity and sequential regulation to the 
cAMP/PKA signaling pathway (Tasken et al., 2004). 
 
Figure 5. Subcellular localization and binding partners for some AKAP scaffolding complexes (Taken 
from, Wong and Scott, 2004). 
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Protein phosphatases 
The action of protein kinases is counterbalanced by dephosphorylation mediated by 
protein phosphatases. The nucleus contains many phosphatases involved in cell cycle 
progression, DNA replication, transcription and RNA processing. Surprisingly, there are 
2-5 times fewer protein phosphatases than kinases, and when analysis is limited to 
Ser/Thr phosphatases, there are 20 times fewer Ser/Thr phosphatases than kinases 
(Bollen, 2001). However, the catalytic subunits of protein phosphatases can form 
complexes with over 50 different regulatory subunits (also referred to as ‘R’) in an 
exclusive or combinatorial manner (Bollen, 2001; Cohen, 2002b). This enables a very 
accurate spatiotemporal regulation of dephosphorylation events in the cell. 
 
Protein phosphatase 1 
PP1 is one of the most conserved enzymes in eukaryotes (Ceulemans and Bollen, 2004) 
(Fig. 6). PP1 is a Ser/Thr phosphatase involved in the regulation of cellular processes 
such as muscle contraction, gene expression, glycogen metabolism, mRNA splicing and 
neurotransmission (Ceulemans et al., 2004). PP1 is also implicated in RNA/pre-mRNA 
processing (Hirano et al., 1996; Boudrez et al., 2000; Novoyatleva et al., 2008), mitosis 
exit (Fernandez et al., 1992) and NE assembly (Steen et al., 2000b). Mammals have three 
PP1 genes, encoding the PP1, PP1/ and PP1(1 and 2) isoforms. With the exception of 
the testis-enriched PP12, the mammalian isoforms are ubiquitously expressed into 
multiple cellular compartments. Even though isoforms of the catalytic subunit (PP1c, 
referred to as PP1) display ~90% sequence identity at the amino acid level, the isoforms 
probably execute distinct functions in vivo as some regulatory subunits bind PP1 in an 
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isoform-specific manner and the phenotype of a functional loss of PP1 is isoform-specific 
(Schillace and Scott, 1999; Cheng et al., 2000; Raghavan et al., 2000). 
 
 
 
 
 
 
 
 
 
Figure. 6. Structure of PP1c. Two views of residues 7-300 of the  isoform of mammalian PP1c are 
shown. (a) The catalytic site (green) and the 12-13 loop (magenta), required for inhibition by various 
inhibitory R subunits are shown. (b) The RVXF binding pocket (purple) and the IKGI sequence in the N-
terminal domain of Inhibitor-2 (cyan) are shown (Bollen, 2001). Other surface residues (orange) are 
essential for optimal interaction with R subunits (Ramaswamy et al., 1998) (taken from Bollen 2001).  
 
The catalytic subunits of PP1 do not exist freely in the cell, but associate with 
many R subunits to form distinct multimeric holoenzymes. The PP1 holoenzyme consists 
of a single catalytic subunit and one or two R subunits (Aggen et al., 2000; Bollen, 2001; 
Ceulemans et al., 2002; Cohen, 2002a). R subunits can act as inhibitors of PP1c, 
activators of PP1c or act as substrate specifiers that increase PP1 activity towards certain 
substrates and decrease it towards others (Ceulemans et al., 2004).  
 Various examples include: nuclear inhibitor of PP1 (NIPP1) is a nuclear targeting 
regulatory subunit implicated in RNA processing (Bollen and Beullens, 2002). Myosine 
phosphatase targeting (MYPT) subunit (Hirano et al., 1999) and AKAP149 (Steen et al., 
2003) act as substrate specifiers by promoting PP1 activity towards myosin light chain 
and B-type lamins, respectively, whereas both inhibit PP1 activity towards phosphorylase 
a in vitro (Johnson et al., 1997; Steen et al., 2003). NIMA related kinase 2 (Nek2), 
involved in maintenance and modulation of centrosome architecture (Mi et al., 2007), is a 
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PP1 regulatory subunit in addition to being a PP1 substrate (Helps et al., 2000). For other 
PP1 interactors, such as phosphofructokinase (PFK), the retinoblastoma protein (Rb), and 
Sla1, it is not yet clear whether they are regulators and/or substrates of PP1, or whether 
they bind directly to PP1 or via another interactor (Ceulemans et al., 2004). The large 
diversity of PP1 holoenzymes provides the cell with a precise regulation of PP1-mediated 
dephosphorylation in a localization- and substrate-specific manner. 
 
PP1 regulatory subunits 
An interesting question is how PP1 can interact with a large selection of subunits that are 
not structurally related and that have distinct effects on the activity and substrate 
specificity of the phosphatase. Evidence has demonstrated that 1) R subunits typically 
bind to PP1c via a short (4-6 residues) degenerate sequence motif 2) most R subunits 
have multiple interaction sites with PP1; and 3) R subunits can share PP1 interaction 
sites. The best characterized PP1 binding site within R subunits, is the so-called ‘RVXF’ 
motif (where X is any amino-acid), which forms a hydrophobic groove. The RVXF motif 
serves as an initial anchor for PP1 binding and thereby promotes, sometimes 
cooperatively, binding to secondary sites, which are often of lower affinity for PP1 
(Bollen, 2001; Wakula et al., 2003). 
 
PP1 is involved in RNA regulation and is essential for mRNA splicing 
PP1 activity has been shown to be essential for RNA splicing (Mermoud et al., 1992; 
Boudrez et al., 2000; Novoyatleva et al., 2008) and in the nucleus, PP1 interacts with the 
splicing factor polypyrimidine tract-binding protein-associated splicing factor (PSF) 
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(Hirano et al., 1996). PP1-mediated dephosphorylation is involved in structural 
rearrangements necessary for the transition from the first to second step of splicing. PP1 
associates with complexes formed on pre-mRNA (Hirano et al., 1996). However, binding 
partners and dephosphorylation targets of the phosphatase in the spliceosome are largely 
unknown. 
 Transformer2-beta1 (tra2-beta1), similar to an SR-protein (family of splice-
factors essential in splicing that always contains a SR domain) that regulate splice site 
selection by recruiting regulatory proteins to exon sequences, contains a conserved PP1 
binding motif (Novoyatleva et al., 2008). Interestingly, this binding RVDF motif is 
located in the RNA recognition motif (RRM) and binds PP1 (Novoyatleva et al., 
2008).The PP1-binding motif is also conserved in the beta-4 strand of eight other RRMs, 
including those of SF2/ASF, SRp30c and polypyrimidine tract-binding protein (PTB) 
(Novoyatleva et al., 2008).This illustrates an important role for PP1 regulation in RNA 
metabolism. 
 
Involvement of PP1 in chromosome dynamics during the cell cycle 
PP1 is important for mitosis exit in yeast, fungi and mammalian cells (Ohkura et al., 
1989; Doonan and Morris, 1989; Fernandez et al., 1992; Alberts et al., 1993; Hisamoto et 
al., 1994; Steen et al., 2000b), and a significant part of PP1 co-localizes with 
chromosomes, centromeres and spindle at mitosis (Fernandez et al., 1992; Trinkle-
Mulcahy et al., 2001). PP1 has been shown to dephosphorylate Rb allowing cells to exit 
mitosis, (Rubin et al., 1998; Berndt, 1999;Rubin et al., 2001; Udho et al., 2002). PP1 also 
maintains nuclear lamins in a dephosphorylated form at NE throughout G1, thereby 
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maintaining nuclear integrity (Steen et al., 2003). Furthermore, inhibition of PP1 activity 
at metaphase results in metaphase arrest (Fernandez et al., 1992), whereas PP1 inhibition 
during anaphase prevents completion of cell division. Conversely, increasing level of PP1 
at anaphase accelerates completion of cytokinesis (Fernandez et al., 1992). The ‘recruits 
PP1 onto mitotic chromatin at anaphase’ (Repo-Man)-PP1 complex was also recently 
shown to play a critical role in the maintenance of chromosome architecture during 
mitosis, probably at the level of condensin regulation (Vagnarelli et al., 2006; Trinkle-
Mulcahy et al., 2006). In Paper I in this thesis, PP1 is proposed to regulate chromatin 
decondensation at the end of mitosis through the R subunit PNUTS/p99. 
  
PP1 nuclear targeting subunit (PNUTS) 
PNUTS/R111/p99 (Kreivi et al., 1997; Allen et al., 1998; Kim et al., 2003) is a nuclear 
PP1 targeting and R subunit found in most tissues in human and rat (Allen et al., 1998). 
Yeast two-hybrid screening and immunoprecipitation assays (Allen et al., 1998) show 
that both PP1 and PP1 isoforms interact with PNUTS (Allen et al., 1998). Expression 
profile of PNUTS in rat brain cortex development shows a continual decrease in 
expression to a low protein level in the adult, which suggests a role for PNUTS in brain 
development (Allen et al., 1998). Interestingly, PNUTS has been found to be down-
regulated in brain samples from patients with Alzheimer disease as well (Raha-
Chowdhury et al., 2005). PNUTS has also been implicated in the regulation of p53 
expression and phosphorylation under mild hypoxia conditions, a function dependent on 
an intact PP1 binding domain (Lee et al., 2007b). Furthermore PNUTS:PP1 dissociation 
under mild hypoxia leads to activation of PP1, dephosphorylation of Rb, and cell cycle 
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arrest in G1 (Lee et al., 2007b). PNUTS, therefore, may represent an interesting new 
target for tumor treatment by enhancing sensitivity to hypoxia-induced cell death (Lee et 
al., 2007b).  
 PNUTS also acts as a substrate specifier of PP1. For instance, PNUTS suppresses 
the phosphatase activity of PP1 toward phosphorylase a by >90% (Kreivi et al., 1997), 
indicating that PNUTS is a PP1 inhibitor towards this substrate in vitro. On the other 
hand, Paper I in this thesis suggests that PNUTS associated with PP1 does not inhibit but 
rather activates PP1 in the process of chromosome decondensation, at least in a cell-free 
system. The PP1 interaction domains of PNUTS consists of a degenerate RVXF 
(LTVTW) motif and an inhibitory domain (ETARRL), mapped to, respectively, amino 
acids 396-401 (Kreivi et al., 1997; Kim et al., 2003) and 445-450 (Kim et al., 2003). 
Association of PNUTS with the PP1 catalytic subunit is regulated by phosphorylation 
through the PKA consensus motif containing T398, where by phosphorylation of T398 
by PKA reduces PP1c-PNUTS association (Kim et al., 2003). 
 Subcellular localization of PNUTS varies during the cell cycle. During interphase, 
PNUTS is intranuclear (Kreivi et al., 1997; Allen et al., 1998). Upon entry into mitosis, 
PNUTS is dispersed in the cytoplasm and is clearly dissociated from chromosomes 
(Kreivi et al., 1997; Allen et al., 1998). PNUTS immunolabeling appears diffuse at 
anaphase, whereas at telophase PNUTS relocalizes to the reforming nucleus (Allen et al., 
1998). Paper I shows the cell cycle-dependent localization of PNUTS and suggests a role 
for PNUTS on chromosome dynamics in a cell-free nuclear reassembly system. These 
findings form a working hypothesis for Paper I presented in this thesis.  
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A kinase anchoring protein 149 (AKAP149)/AKAP121/dAKAP1 
Description 
AKAP149 is a dual PKA-anchoring and PP1-binding protein, and in addition functions as 
a substrate-specifier. AKAP149 contains 903 amino acids and harbor several functional 
domains. AKAP149 has an N-terminal (residues 1-30) mitochondrial/NE/ER anchoring 
domain, two consensus PP1-binding motifs (residues 153-157 and 627-631), a RII/RI 
binding domain (residues 355-376), a leucine zipper (residues 310-338) and single KH 
(residues 612-659) and TUDOR (residues 708-829) motifs in the far C-terminal (Fig. 
7)(Trendelenburg et al., 1996). 
 
Figure 7. AKAP149 with interaction domains and functional domains identified to date. 
 S-AKAP84 (Lin et al., 1995), D-AKAP1 (Huang et al., 1999), AKAP149 
(Trendelenburg et al., 1996) and its mouse homolog AKAP121 (Chen et al., 1997) arose 
by alternative splicing of the akap1 gene (Fig. 8.). These isoforms share a 525 amino acid 
NH2-terminal core, containing the PKA binding domain, but differ in their COOH- and 
NH2-terminal sequences. At least four different COOH-terminal splice-variants have 
been identified, in addition to several NH2-terminal splice-variants (Huang et al., 1999; 
Ma and Taylor, 2008). S-AKAP84, D-AKAP1, AKAP121 and AKAP149 all target 
mitochondria (Cardone et al., 2002; Cardone et al., 2004; Rogne et al., 2006; Dyson et 
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al., 2008). However, several reports in mouse indicate that two alternative splice variants 
in the NH2-terminus of D-AKAP1 direct it either to mitochondria (AKAP1c) or to the 
endoplasmic reticulum (ER) (AKAP1d) (Huang et al., 1999; Ma and Taylor, 2002; Ma et 
al., 2008). Moreover, a PKA-RII overlay assay has identified AKAP149 in purified NE 
extracts from HeLa cells (Steen et al., 2000b). This suggests that AKAP149 together with 
its splice variants (Fig. 8) localizes to the mitochondria or ER/NE network presumably 
depending on its NH2-terminal localization signal.  
 
Figure 8. Characterized splice variants of D-AKAP1. AKAP1 has 4 different C-terminal splice variants, 
two of which (AKAP1a and AKAP1c/AKAP121/AKAP149) also contain a NH2-terminal splice variant 
(AKAP1b and AKAP1c, respectively). AKAP1c and AKAP121/149 are the same protein, although they 
derive from slightly different mRNAs. 
 S-AKAP84 is testis specific (Furusawa et al., 2002), and AKAP1d has only been 
detected in liver (Huang et al., 1999). On the other hand AKAP1c/AKAP149/AKAP121 
expression is more ubiquitous and has been detected in heart, brain, lung, liver, skeletal 
muscle, kidney, testis, but not in spleen (Huang et al., 1999). AKAP149/121 is also 
expressed in oocytes under maturation, in brown fat tissue and differentiated adipocytes 
(Ranganathan et al., 2002; Yukitake et al., 2002; Chaudhry et al., 2002; Webb et al., 
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2008). Thus, when considering all isoforms, the distribution of AKAP149 is relatively 
ubiquitous.  
Binding partners of AKAP149 
AKAP149 emerges as a multiscaffolding AKAP, with a growing number of known 
interaction partners (Lin et al., 1995; Trendelenburg et al., 1996). AKAP149 binds both 
the RI and RII regulatory subunits of PKA in vitro, which makes it a dual AKAP (Huang 
et al., 1999; Carlson et al., 2003). AKAP149 contains two PP1 binding motifs, the NH2-
terminal one associates with PP1 in an in vitro overlay assay. PP1 binding was also 
shown by immunoprecipitation in HeLa cells (Steen et al., 2000b; Steen et al., 2003; 
Kuntziger et al., 2006). AKAP149 was shown to be a substrate specifier of PP1, since the 
AKAP149:PP1 complex inhibits PP1 activity towards phosphorylase a but enhances PP1 
activity towards B-type lamins (Steen et al., 2003).  
 AKAP149 co-precipitates PKC, and in vitro assays indicate that AKAP149-bound 
PKA and PKC serine phosphorylate immunoprecipitated AKAP149, and that PKC 
phosphorylation promotes dissociation of PP1 from the AKAP (Kuntziger et al., 2006). 
These results suggest a putative temporally and spatially controlled mechanism where 
PKC promotes the release of PP1 from the NH2-terminal of AKAP149 presumably in a 
cell-cycle-dependent manner (Kuntziger et al., 2006). 
 Moreover, AKAP121/149 targets the Src Tyr kinase to mitochondria via 
association with protein tyrosine phosphatase D1 (PTPD1) (Cardone et al., 2004). PTPD1 
is a widely expressed cytostatic non-receptor Tyr phosphatase, a positive regulator of Src 
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signalling and a key component of the epidermal growth factor (EGF) transduction 
pathway (Cardone et al., 2004). By binding and targeting the phosphatase to 
mitochondria, AKAP121 may be involved in the regulation of the Src-dependent EGF 
transduction pathway (Livigni et al., 2006). In one report, AKAP121/149 was also shown 
to bind PDE4A in T lymphocyte cells (Asirvatham et al., 2004). The biological function 
for this interaction is unknown at present but provides interesting new possibilities for a 
fine-tuned regulation of PKA-mediated phosphorylation in mitochondria. 
 Other binding partners for AKAP149 in addition to the ones described above are 
known. The NH2-terminal mitochondrial targeting domain of AKAP84/149 associates 
with -tubulin (Cardone et al., 2002) and the RII binding domain binds with associated of 
Myc-1 (AMY1) (Furusawa et al., 2001; Furusawa et al., 2002). Association with AMY1 
and PKA to AKAP149 is mutually exclusive, causing bound AMY-1 to inhibit 
AKAP149-related PKA activity in mitochondria (Furusawa et al., 2002). As discussed 
below the KH domain of AKAP149 also binds RNA. Taken together, the growing 
number of AKAP149 interaction partners leads to the postulation that AKAP149 
functions as a scaffolding protein for several signalling molecules (Fig. 9) 
 
Figure 9. AKAP 149 and known binding partners. 
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 Biological functions 
A growing number of reports implicate AKAP149 in different biological functions. 
Functions involving the PKA binding domain, PP1 binding motif and the K Homology 
(KH) domain are the most described. AKAP149 directed PKA localization in the outer 
mitochondrial membrane increases PKA-dependent phosphorylation and inactivation of 
the proapoptotic protein Blc-2 agonist in the cell (BAD) and enhances cell survival 
(Harada et al., 1999; Affaitati et al., 2003; Livigni et al., 2006). Furthermore, regulation 
of AKAP121/149 protein levels by ubiquitination and proteosomal degradation is 
important to allow PKA activity to fluctuate rapidly in the cell in response to changes in 
oxygen levels (Carlucci et al., 2008). A role for AKAP121/149 in oxidative metabolism 
and cell survival has also recently been proposed (Carlucci et al., 2008). Interestingly 
AKAP149 is a substrate of active caspases-3, -8 -and -10 in vitro and in vivo when 
apoptosis is induced (Yoo et al., 2008). Caspases play a central role by transducing and 
amplifying the intracellular death signal, and apoptosis is executed as a consequence of 
caspase-mediated cleavage of multiple cellular substrates (Yoo et al., 2008). Collectively, 
the results reveal the importance of AKAP149 in cell survival. In addition, AKAP1 
knock-out mice with an interrupted PKA localization to mitochondria show oocyte 
maturation failure, supposedly due to the inability to remove PKA from the nucleus in 
meiosis division two (Newhall et al., 2006; Webb et al., 2008). Consequently females are 
sterile (Newhall et al., 2006). These results again demonstrate the importance of 
spatiotemporal regulation of PKA in many important biological functions.  
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 As mentioned earlier, previous work from our laboratory has shown that 
AKAP149 acts as a PP1 targeting subunit to the reforming NE in vitro at mitosis exit 
(Steen et al., 2000b; Steen et al., 2003), and that NE reassembly at the end of mitosis 
requires targeting of B-type lamin and PP1 to the NE by AKAP149 (Steen et al., 2000b). 
Furthermore, PP1 remains associated with NE bound AKAP149 throughout G1 but is 
released from AKAP149 during S phase entry, as AKAP149 becomes Ser-
phosphorylated (Steen et al., 2003). This suggests that AKAP149 associates with PP1 in 
a cell-cycle dependent manner, and has an important role in regulating PP1 function upon 
exit from mitosis. 
 AKAP149 and AKAP121 are identical in the COOH-terminal region that contains 
the KH and Tudor domain. The hnRNP K homology (KH) domain was first identified in 
the heterogenous nuclear ribonucleoprotein K (hnRNP K) 14 years ago(Siomi et al., 
1993). KH domain-containing proteins are responsible for specific binding/regulation of 
mRNAs and ssDNA in the cell, such as mRNA transport, post-transcriptional regulation 
of mRNA and RNA splicing (Siomi et al., 1994; Nagai, 1996; Grishin, 2001; Tadesse et 
al., 2008; Herr et al., 2008; Bouvrette et al., 2008). The KH domain of AKAP149/121 
has also been implicated in binding to mRNA (Ranganathan et al., 2002; Ginsberg et al., 
2003; Ranganathan et al., 2005; Dyson et al., 2008). The KH domain of AKAP149 binds 
in vitro to the 3’ untranslated region (UTR) of several mRNAs such as the mitochondrial 
protein manganese superoxide dismutase (MnSOD), the mitochondrial ATP synthase 
subunit (Fo-F), the steroidogenic acute regulatory protein (mStar) and the adipose 
specific lipoprotein lipase (LPL) (Ranganathan et al., 2002; Ginsberg et al., 2003; 
Ranganathan et al., 2005; Dyson et al., 2008). RNA binding is suggested to be dependent 
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on PKA-mediated phosphorylation of the KH domain, and AKAP121/149-anchored PKA 
may be responsible for this phosphorylation (Ginsberg et al., 2003). The regulation 
exerted by AKAP149/121 on the mRNA could be individual, for instance AKAP121-
MnSOD mRNA binding might result in higher level of MnSOD mRNA translocation 
from the cytosol to mitochondria (Ginsberg et al., 2003), whereas the AKAP121-PKA-
LPL mRNA complex leads to translational decrease of LPL protein in pre-adipocytes 
(Ranganathan et al., 2005). The latter may explain the decrease in LPL activity following 
catecholamine signalling, which is known to induce PKA (Morita et al., 1998; 
Ranganathan et al., 2005; Unal et al., 2008). The function of the KH domain of 
AKAP149, which interestingly contains a PP1-binding motif and RNA binding features 
in its core, is a significant part of the results presented in this thesis (Papers II, III, IV). 
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AIMS OF THE STUDY 
Many cellular functions are regulated by reversible protein phosphorylation. cAMP-
dependent protein kinase A (PKA) and protein phosphatase 1 (PP1) are two well 
characterized effectors involved in many essential phosphorylation-dependent processes. 
Accurate signaling by PKA and PP1 i.e., phosphorylation/dephosphorylation of target 
substrates, require precise spatio-temporal regulation of these signaling molecules. This 
thesis focuses on two phospho-regulating proteins, PNUTS and AKAP149. Aims of the 
work presented in this thesis were to: 
 
1. Investigate the role of the PNUTS:PP1 holoenzyme on chromosome 
decondensation in a cell-free system. 
2. Investigate the role of the KH and TUDOR domains of AKAP149 on AKAP 
dimerization and association with RNA, in vivo. 
3. Further elucidate the PP1-binding features of AKAP149 in the context of its two 
PP1-binding motifs and of RNA association. 
4. Develop a simple, rapid and efficient RNA immunoprecipitation protocol to 
identify novel protein-RNA interactions. 
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SUMMARY OF RESULTS 
PUBLICATION I 
PNUTS enhances in vitro chromosome decondensation in a PP1-dependent manner 
PP1 is a Ser/Thr phosphatase involved in mitosis exit and chromosome decondensation. 
In this study, we characterize the subcellular and subnuclear distribution of PNUTS, a 
nuclear regulatory subunit of PP1. In interphase, PNUTS co-fractionates with PP1 and 
with chromatin. Immunofluorescence analysis indicates that PNUTS is targeted to the 
reforming nuclei at the end of mitosis, after nuclear envelope assembly, as chromatin 
decondenses. In interphase cytosolic extract, ATP-dependent decondensation of 
prometaphase chromosomes is blocked by PP1-specific inhibitors. In contrast, a 
recombinant PNUTS (309-691) fragment accelerates chromosome decondensation. 
Decondensation-promoting activity requires the consensus RVXF PP1-binding motif of 
PNUTS, whereas a secondary, inhibitory PP1-binding site is dispensable. In a buffer 
system depleted of cytosolic factors, PNUTS (309-691) and PP1, in the presence of an 
ATP generating system, promote chromosome decondensation. These results indicate an 
involvement of the PP1:PNUTS holoenzyme in chromatin decondensation and argues 
that PNUTS functions as a PP1-targeting subunit in this process. 
 
PUBLICATION II 
The KH-Tudor domain of A-kinase anchoring protein 149 mediates RNA-
dependent self-association 
A-kinase anchoring proteins (AKAPs) control the subcellular localization and temporal 
specificity of protein phosphorylation mediated by cAMP-dependent protein kinase. 
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AKAP149 (AKAP1) is localized in mitochondria and in the endoplasmic reticulum-
nuclear envelope network, and anchors protein kinases, phosphatases, and a 
phosphodiesterase. AKAP149 harbors in its COOH-terminal part one K-homology (KH) 
domain and one Tudor domain, both known to be involved in RNA binding. In this 
article we show that AKAP149 self-associates in an RNA dependent manner through the 
KH domain. This KH domain is sufficient for self-association of AKAP149 in a RNA-
dependent manner. However, the Tudor domain is required together with the KH domain 
for targeting to well-defined nuclear foci. These foci are spatially closely related to 
nucleolar subcompartments coilin and UBF. We also show that a fragment of AKAP149 
containing the KH-Tudor domains of AKAP149 binds RNA in vitro and in RNA 
immunoprecipitation experiments. AKAP149 emerges as a scaffolding protein involved 
in intracellular signaling and possibly RNA metabolism or post-transcriptional control. 
 
PUBLICATION III 
Mutually exclusive binding of PP1 and RNA to AKAP149 affects the mitochondrial 
network 
The K-homology (KH) domain of A-kinase anchoring protein (AKAP)149 contains an 
uncharacterized conserved PP1 binding RVXF motif in the RNA binding groove. In this 
paper we set out to define the functional importance of PP1 and RNA binding to the KH 
domain of AKAP149. We show that PP1 binding occurs through the conserved RVXF 
motif in the KH domain, and that PP1 and RNA binding to this same site is mutually 
exclusive and controlled through a novel, phosphorylation-dependent mechanism. A 
collapse of the mitochondrial network is observed upon overexpression of RNA-binding 
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deficient mutants in the KH domain of AKAP149. The results point to the importance of 
RNA tethering of the mitochondrial membrane by AKAP149 for mitochondrial 
distribution. 
 
PUBLICATION IV 
QuickRIP – Cross-linked RNA immunoprecipitation  
Nucleic acid binding proteins constitute nearly one-fourth of all functionally annotated 
human genes. Genome-wide analysis of protein-nucleic acid contacts has not yet been 
performed for most of these proteins, restricting attempts to establish a comprehensive 
understanding of protein function. In this paper we aimed to identify the RNA(s) binding 
to the K-homology (KH) domain of A-kinase anchoring protein (AKAP)149 in vivo, by 
developing an improved cross-linked RNA immunoprecipitation (RIP) assay (QuickRIP). 
Our protocol is faster, easier, cleaner and applicable to a broader range of proteins than 
previously developed RIP protocols. RIP conditions allow us to proceed with RNA for 
cloning or potentially hybridization to a full-genome cDNA chip. The RIP assay reveals a 
phosphorylation-dependent regulation of RNA binding to AKAP149, and demonstrates 
direct RNA binding to AKAP149 through the conserved GxxGxxV hydrophobic pocket 
in the KH domain. The method provides a powerful tool to elucidate the regulation of 
protein:RNA binding regulation in vivo, and advances the probability of revealing novel 
protein:RNA interactions. 
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DISCUSSION 
Phosphorylation constitutes an essential switch in many processes in the body such as 
cell-growth and division, neuronal function and fertility. Studies presented in this thesis 
aim to give insights on the function of the conserved protein phosphatase 1 (PP1) through 
the study of two of its regulatory subunits: PNUTS and AKAP149. Regulation of PP1- 
and RNA binding (Paper III), methods used (Paper I and IV) and potential biological 
relevance (Paper I, II, III and IV) are discussed. 
 
A role for PNUTS in mitosis 
PNUTS is involved in chromosome decondensation in vitro 
In vitro systems to study chromosome decondensation 
In vitro systems such as that used in Paper I for investigating functions of the 
PNUTS:PP1 holoenzyme have been used to study chromatin-related events occurring in 
mitosis (Lohka and Masui, 1984b; Wood et al., 1990; Collas et al., 1999a; Steen et al., 
2000a). Under proper conditions and using sperm as chromatin templates, frog egg 
extracts can recapitulate chromosome decondensation, NE assembly, initiation of DNA 
synthesis and subsequent chromosome re-condensation (Lohka et al., 1984a; Lohka et 
al., 1984b; Lohka et al., 1985). Similarly, mitotic mammalian cell extracts can allow 
chromosome condensation from heterogenous nuclei to take place (Wood et al., 1990; 
Collas et al., 1999b; Steen et al., 2000a). In Paper I, we introduce a related method where 
mitotic chromosome clusters isolated from nocodazole-treated HeLa cells were incubated 
in interphase HeLa cell cytosolic extract to study chromosome decondensation. 
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 An advantage of such cell-free systems is that they provide experimental control 
by the addition and/or removal of specific components to investigate a specific function. 
For instance in our in vitro system, an ATP-generating system was necessary to enhance 
the efficiency of chromosome decondensation, reflecting the energy-dependent nature of 
this process in vivo (Cameron and Poccia, 1994). Alternatively, the number of unknown 
factors in a cell extract can be reduced by substituting the extract with a buffer containing 
an ATP generating system, an approach used here to identify a more direct effect of the 
PNUTS:PP1 holoenzyme on chromosome decondensation.  
 Although an in vitro system may provide initial indications of a biological 
function, it may not always reflect in vivo biological activities. For example, 
immunodepletion of condensin I from frog egg extracts inhibits in vitro chromosome 
condensation (Hirano et al., 1997); however, siRNA knockdowns of condensins I and II 
do not inhibit completely chromosome condensation in vivo, indicating that condensins 
alone are not essential for chromosome condensation (Ono et al., 2003). Nevertheless, 
sister chromatid separation and chromosome segregation defects were noted, arguing for 
important roles for condensins in the regulation of mitotic chromosome condensation 
(Ono et al., 2003). We show here that PP1 and PNUTS together promote mitotic 
chromosome decondensation from chromosome clusters, both in an interphase HeLa 
extract and in a buffer system (Paper I). One potential bias in here could be that proteins 
essential for chromosome decondensation are not fully stripped from chromosome 
clusters during purification. Nonetheless, there is a significantly higher level of 
chromosome decondensation in the PNUTS:PP1 condition compared to the control 
conditions with PP1 alone or with other known PP1 inhibitors. 
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 Substrate(s) of the PNUTS:PP1 holoenzyme important in chromosome 
decondensation remain(s) unidentified. However, several substrates of PP1 during 
mitosis exit, such as H1, H2A, H3, H4, Retinoblastoma protein (pRb), condensins and 
topoisomerase II can be considered as candidates. Since PNUTS has been reported to 
inhibit PP1 activity towards pRb, and hyperphosphorylation of pRb is necessary for the 
cells to mitosis exit (Krucher et al., 2006; De et al., 2008), pRb represents a very 
promising candidate substrate for the PNUTS:PP1 holoenzyme. However, PNUTS seems 
to act as an inhibitor of PP1 toward Rb dephosphorylation (De et al., 2008), and in our 
assays the inhibitory domain of PNUTS was dispensable for chromosome 
decondensation. We also show chromosome decondensation in a buffer system which is 
devoid of pRb since cell fractionation studies have shown that pRb is soluble in mitosis 
and likely not associated with chromosome clusters (Nelson and Ludlow, 1997). This 
indicates additional role(s) for the PNUTS:PP1 holoenzyme other than to inhibit pRb in 
mitosis exit. 
 H1 and topoisomerase II have both been shown to have reduced phosphorylation 
levels in anaphase (Paulson et al., 1996; Ishida et al., 2001). Topoisomerase II is 
phosphorylated on four Ser residues upon mitosis entry (Hackbarth et al., 2008) and 
could therefore potentially be dephosphorylated by PP1 at mitosis exit. Also, H1 
dephosphorylation towards mitosis exit is inhibited by the PP1 and 2 inhibitor okadaic 
acid, suggesting PP1 as a likely candidate for H1 dephosphorylation at anaphase. Since 
PNUTS is a regulatory subunit for PP1 activity in mitosis exit in vitro, the PNUTS:PP1 
holoenzyme may be involved in dephosphorylation of the potential PP1 substrates 
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mentioned above. However, in vivo substrates for the PNUTS:PP1 holoenzyme in 
chromosome decondensation remain to be determined. 
  
Is PNUTS involved in checkpoint regulation in G2? 
Interestingly, after Paper I was published, the functions of the PNUTS:PP1 holoenzyme 
have been further examined in our laboratory in an in vivo context (Landsverk et al., 
unpublished data). Surprisingly, knockdown of PNUTS by siRNA did not delay 
chromosome decondensation in telophase, cells were instead delayed in G2/prophase and 
showed difficulties to enter mitosis (Fig. 10). 
 
 
Figure 10. PNUTS depleted cells are arrested in prophase. (A and B) Scrambled siRNA transfected (A) or 
PNUTS siRNA (B) transfected HeLa cells were imaged by live cell confocal microscopy during entry into 
mitosis. Prophase is defined as the period between first visible signs of mitotic chromosome condensation 
and ‘collapse’ of chromosomes at the time of NE breakdown. Transition shown in -7 to 0 min in control 
condition (A) while PNUTS siRNA transfected cells remains longer in prophase (B). (C) Statistics on 
average time spent in the various stages of mitosis; prophase, promethaphase, methaphase, anaphase amd 
telophase, as indicated (Landsverk et al., unpublished data).  
 
 Furthermore, -irradiation of HeLa cells to activate the G2 checkpoint revealed an 
increase in the population of cells delayed in G2 for PNUTS siRNA-depleted cells 
(Landsverk et. al. unpublished data). It is tempting to speculate that this G2 delay results 
from the impossibility for PNUTS:PP1 to dephosphorylate G2 check-point complexes 
like Cdc25 or ATM, an event required for re-entry into the cell cycle and into mitosis 
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(Kaufmann, 1998). Also, and as mentioned earlier, PNUTS can inhibit PP1 activity 
towards pRb, possibly also linking PNUTS to regulation of the cell cycle by preventing 
mitosis exit and allowing apoptosis (De et al., 2008). Collectively, recent investigations 
strengthen the case for an important role for PNUTS in chromatin-related regulatory 
events in the nucleus in mitosis, although the precise mechanisms remain unrevealed to 
date.  
 
Regulation of PP1 binding and activity by phosphorylation-dependent 
switches in the regulatory subunits 
Paper III describes a mutually exclusive phosphorylation-dependent binding of PP1 or 
RNA to the KH domain of AKAP149. PP1 binds when Ser630 is dephosphorylated, 
whereas RNA binds when Ser630 is phosphorylated. Phosphorylation events in or close 
to the RVXF motif of PP1 R subunits can abolish PP1 binding, or PP1 activity towards a 
given substrate (Margolis et al., 2003; Kwiek et al., 2006). The PP1-binding site in the 
KH domain of AKAP149 contains a conserved PKA phosphorylation site at Ser630 
which potentially adds another layer to the regulation of PP1 and RNA binding. 
Phosphorylation of Ser287 of Cdc25, another PP1 R subunit, results in its binding to 
protein 14-3-3 which in turn inhibits PP1 phosphatase activity towards this residue, 
leading to G2 arrest (Margolis et al., 2003). Notably, Ser287 of Cdc25 can also be 
phosphorylated by PKA in vitro (Duckworth et al., 2002). Interestingly, PNUTS as well 
harbors a conserved potential PKA phosphorylation site (Ser398) in its RVXF motif and 
the RVXF motif overlaps with a potential 14-3-3 binding site (Fig. 11). This pleads for 
further PNUTS:PP1 binding regulation experiments, including PP1 and 14-3-3 mutants to 
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study cell-cycle regulation, nucleocytoplasmic localization and cell viability (Fig. 12). 
Our findings raise the attractive possibility of a phosphorylation-dependent switch for 
binding of PP1 (or other proteins) or RNA in a mutually exclusive manner to the same 
residues on a multivalent anchoring protein. How frequent this mechanism is uncertain, 
but in any event, it appears to provide another level of regulation to keep PP1 activity 
under strict control in the cell (Fig. 12). 
 
Figure 11. PNUTS with potential and known binding domains. The PP1 binding RVXF is highlighted 
together with a potential PP1 binding regulatory phosphorylation site. A potential 14-3-3 binding site is 
also shown. 
 
 
 
Figure 12. Hypothetical model of PP1 binding regulation to the regulatory subunit (R). When R is in a 
dephosphorylated state PP1 may bind. Upon phosphorylation PP1 is released from its regulatory subunit 
and replaced with binding to 14-3-3, RNA or an unknown protein X. Binding of 14-3-3/RNA/X to the R 
subunit prevents PP1 activity by inhibiting association with the PP1 R subunit or access to the 
phosphorylation site or both. 
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Presence of several PP1 binding motifs in the same regulatory subunit 
In Paper III we characterize a RVXF PP1 binding motif inside the KH domain of 
AKAP149, and compare it to the previously described RVXF motif situated in the NH2-
terminal of AKAP149 (Steen et al., 2000b). It has been shown that at least two other 
regulatory subunits of PP1 also have two RVXF motifs, namely Sipp1 (Llorian et al., 
2004) and Aurora A kinase (Katayama et al., 2001). For Sipp1, both RVXF motifs seem 
to bind PP1 as only a double RAXA mutation of both RVXF motifs completely abolishes 
PP1 binding (Llorian et al., 2004). Our results indicate that under our conditions the 
COOH-terminal RVXF motif binds PP1 significantly more that the NH2-terminal one for 
which no binding was detected by immunoprecipitation. This could be due to 1) the NH2-
terminal binding site not binding PP1 under our experimental conditions, 2) the NH2-
terminal binding site not having strong enough affinity for PP1c for other binding 
partners already present to be displaced, 3) the NH2-terminal associating exclusively with 
the  isoform of PP1 since we only used PP1 and PP1 in our studies, 4) the NH2-
terminal binding site binding PP1 only in very specialized cells or cellular processes, 5) 
wrong NH2-terminal anchoring signal to allow PP1 binding to the NH2-terminal 6) 
requirement for additional areas outside our construct to enhance PP1c binding for it to 
become detectable. The COOH-terminal RVXF is identical in mouse and humans, and 
highly conserved with only one amino-acid difference between fugu fish and humans. 
The NH2-terminal RVXF is not conserved between mouse and humans, maybe 
suggesting a specific involvement in higher primate processes such as memory or 
learning. One intriguing question about the presence of two PP1-binding RVXF motifs in 
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the same regulatory subunit is whether they can be involved in different biological 
processes? 
 It is becoming increasingly clear that PP1 regulatory subunits contain other 
interaction points for PP1 in addition to the conserved RVXF motif (Bollen, 2001; 
Wakula et al., 2003). Moreover, the presence of the RVXF motif alone is not enough to 
affect the activity or conformation of PP1 in a noticeable way; therefore additional 
binding points are necessary for a specific regulatory-subunit effect on PP1. It has been 
proposed that multiple binding domains to PP1 in the regulatory subunits restrict the 
accessibility of the catalytic site by using steric hindrance or by inducing conformational 
changes (Bollen, 2001; Wakula et al., 2003). These changes are able to affect the activity 
and substrate specificity of PP1. In Paper I, we observe that the PP1-binding, but not the 
PP1 inhibitory, domain of PNUTS is required to allow chromosome decondensation in 
vitro. This implies that PNUTS could have another role than to inhibit PP1 in the process 
of chromosome decondensation in vitro, possibly by acting as a substrate specifier for 
PP1 and enhancing PP1 activity towards one or several PP1 substrates in chromatin 
related processes in mitosis. If several PP1 binding regions exist in PNUTS, PNUTS 
could respond differently to cell signaling events by association with PP1 either in a 
substrate specifier, targeting subunit or inhibitor of PP1 context. The exact nature of 
PNUTS:PP1 binding and regulation remains to be revealed. 
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The KH domain as a RNA-binding and a PP1-binding domain 
We indicate in Paper III that binding of PP1 and RNA to the KH domain occurs through 
overlapping residues, is mutually exclusive and inversely controlled by phosphorylation.  
This is to our knowledge the first time RNA and PP1 bind in a mutually exclusive way to 
one and same domain. Until now, it had only been reported that PP1 binds directly to a 
RVXF motif located in the RNA recognition motif (RRM) of tra2-beta1 (Novoyatleva et 
al., 2008), but PP1 binding was not shown to depend on RNA binding and no evidence 
for binding regulation by phosphorylation was provided. Eight other proteins including 
SF2/ASF and SRp30c contain an evolutionary conserved PP1 RVXF motif in their RRM, 
indicating that PP1 binding is a frequent feature of some RNA binding domains 
(Novoyatleva et al., 2008). The discovery of PP1 binding to RNA binding motifs opens 
for a more profound and broader role for PP1 in RNA metabolism, splicing and 
regulation than previously suggested. 
  
AKAP149 self associates through the KH domain in a RNA-dependent 
manner, suggesting a role for AKAP149 in post translational control 
RNA dependent self-association 
KH domains bind RNA or ssDNA, and are found in proteins associated with 
transcriptional and translational regulation, splicing and other cellular processes (Siomi et 
al., 1994; Grishin, 2001; Tadesse et al., 2008). The typical binding surface of a KH 
domain consists of a cleft formed by four unpaired amino acids (GXXG) where van der 
Waals forces, hydrophobic- and electrostatic interactions contribute to nucleic acid 
binding affinity (Valverde et al., 2008). Augmented KH domain or multiple KH domain 
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copies are two strategies used to achieve greater affinity and specificity of nucleic acid 
binding in a protein. In Paper II, we show that AKAP149 binds RNA in vivo and self-
associates in a RNA-dependent manner through the KH domain, as RNAse digestion of 
the extract before immunoprecipitation greatly reduces self-association. RNA-dependent 
self-association has also been indicated for X. laevis Vg1RBP (homologue to human 
KOC protein used as a marker for malignancy in cancer), another KH domain protein 
(Git and Standart, 2002). We show in Paper III that mutations in the KH domain RNA-
binding cleft (V629E or V629AF631E) almost abolishes RNA binding, and the V629E 
mutation also reduces self-association (Paper II). One question remaining is how the 
V629E mutant with strongly reduced RNA binding only shows 50% reduction in self-
association? There are several possible explanations 1) in vivo cross-linking experiments 
as in Paper III reflect RNA bound to AKAP149-EGFP in intact 293 cells, while V629E 
mutation studies in Paper II performed in HeLa cell extracts could result in a larger RNA 
pool of RNA molecules available to associate with AKAP149 2) the V629E mutation 
may result in lower affinity to RNA, possibly too weak or sterically unfavourable for UV 
cross-linking, but still associated to RNA to some extent. One way to explore these 
possibilities further would be to perform in vivo cross-linking followed by RIP on wild-
type or RNA-binding deficient mutants of the KH domain and visualize the protein RNA 
complexes by SDS-PAGE (essentially as performed in Paper III). In vivo cross-linking 
before immunoprecipitation would allow us to look for dimer or trimer complexes of 
AKAP149-RNA and observe how these are affected by mutations in the RNA binding 
groove of the KH domain (V629E or F629AF631A). Collectively, our results indicate 
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that AKAP149 self-associates in a RNA dependent manner through the GxxG binding 
groove of the KH domain. 
 
RNA binding to AKAP149 – preference for methylated residues?  
An interesting feature of KH domains is that they always are more similar to KH domains 
with comparable positions in other proteins than to other KH domains from the same 
protein (Grishin, 2001). Also, KH domains within the same protein have different affinity 
towards the selection of RNAs binding to the protein (Git et al., 2002). AKAP149 only 
contains one KH domain but as indicated in paper II stabilizes RNA binding by self-
association through the KH domain and possibly also through the Tudor domain. Tudor is 
a domain involved in RNA/DNA and protein interactions with a preference for 
methylated residues (Huyen et al., 2004; Cote and Richard, 2005). RNA binding to KH 
often occurs in a dimer or tetramer of different KH domains with distinct affinities for a 
given RNA. Thus a hypothesis is that RNA binding to two identical KH domains 
provided by the AKAP149 dimer would increase the strength of binding to RNA. The 
Tudor domain would provide additional selectivity. Interestingly, AKAP149 contains, 
between the KH and Tudor domain, a conserved potential WW domain binding motif 
(686PPLP689) known to preferentially bind methylated residues (Ryan and Bauer, 2008). 
Moreover, WW domains are implicated in binding to a subset of splicing factors 
including the KH domain-containing hnRNP H, hnRNP M and hnRNP E1, and are able 
to associate to the 3’ part of an intron to form a complex equivalent to the early 
spliceosome (Lin et al., 2004). Whether AKAP149 associates with a WW domain-
containing protein remains unknown at this stage, but one possibility to elucidate this 
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would be to perform initial binding studies with recombinant KH-Tudor fragments of 
AKAP149 on a WW domain array membrane. In the TranSignalTM WW Domain array 
(Panomics, cat no. MA3030) protein interactions take place directly on the WW domain 
array membrane, where potential interaction can be visualized using chemiluminescence. 
The presence of a conserved KH domain, Tudor domain and a potential WW domain 
binding motif, could suggest the COOH-terminal part of AKAP149 is involved in 
selective binding to RNA for post-transcriptional control or for transport to its proper 
localization. The KH, Tudor and WW domain binding motifs also open for the possibility 
of a fine tuned RNA-binding regulation to AKAP149 depending on the methylation mark 
of the RNA, with methylation of certain residues enhancing RNA binding to AKAP149, 
and with phosphorylation of the KH domain a pre-requisite for RNA binding (Paper III). 
 
Possible new unexplored nucleic acid binding features of AKAP149 
In this thesis we explored RNA- and PP1-binding through the COOH-terminal but leave 
another intriguing possible feature of AKAP149 - DNA binding - unexplored. It is an 
attractive hypothesis to test whether AKAP149 binds chromatin, as both the KH domain 
and the Tudor domain have DNA binding properties in other proteins. For instance, 
DDP1 homologue to the highly conserved Vigilin protein, contains 15 KH domains and 
associates preferentially to centromeric satellite DNA sequences in D. melanogaster, and 
further, mutations in the protein suppress heterochromatin mediated silencing (Cortes and 
Azorin, 2000; Steen et al., 2000b; Birchler et al., 2004). The Tudor domain has also been 
demonstrated in several instances to bind DNA, in the context of DNA damage response 
and transcriptional regulation of genes by binding to modified histones. For example, the 
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tandem Tudor domains of 53BP1 are recruited to double-stranded DNA breaks and bind 
to methylated histone H3-K79 (Huyen et al., 2004). Furthermore, a double Tudor domain 
of Jmic domain-containing histone demethylase (JMJD2A) binds methylated histone H2-
K4 and H4-K20 (Huang et al., 2006). Notably, when examining the AKAP149 sequence 
there are several other domains potentially implicated in DNA binding in addition to the 
KH and Tudor domain. This includes the above mentioned WW binding domain shown 
to be involved in preferential binding to methylated DNA(Ingham et al., 2005; Brucet et 
al., 2007). In addition, AKAP149 contains 12 residues corresponding to the 12 first 
residues of a chromodomain (amino-acid 260-271); a domain widely known to have 
important roles in DNA binding and gene regulation (Nielsen et al., 2004; Jacobs et al., 
2004; Lomberk et al., 2006). But the small size of this fragment makes it questionable 
whether it is functional. AKAP149 also contains a leucine-zipper (amino-acid 304-340), 
implicated in chromatin binding, gene regulation, DNA damage response and apoptosis 
(Wang et al., 2006; Miotto and Struhl, 2006; Ciccone et al., 2008). Presence of all the 
motifs mentioned above strongly suggest a possible role for AKAP149 in DNA binding 
and possibly gene regulation. However, one issue to resolve might be to reveal first 
AKAP149 localizations in the cell more precisely, especially how entry into the nucleus 
is possible and how AKAP149 is retained there. Taken together, the possible DNA 
binding features of AKAP149 remain unexplored to date, but open for new important 
biological functions for the AKAP149 scaffolding protein. 
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Towards a model: AKAP149 - mRNA transport - posttranscriptional control 
The RNA-dependent self-association of AKAP149 suggests a role for AKAP149 in RNA 
transport and or post-transcriptional regulation. One attractive scenario may be that 
mRNA molecules sandwiched between two AKAP149 molecules are protected and 
transported to their proper subcellular localization, for instance mitochondria (Fig 13). 
Transport of mRNA from the nucleus to mitochondria by AKAP149 has also been 
suggested for the two mitochondria-specific mRNAs MnSOD and FoF (Ginsberg et al., 
2003). Binding of mRNA to AKAP149 has further been suggested to occur through the 
3’ UTR of several mRNAs (Ranganathan et al., 2002; Ginsberg et al., 2003; 
Ranganathan et al., 2005; Dyson et al., 2008). More generally, it is also increasingly clear 
that mRNA localization is a mechanism involved in the sorting of proteins destined to 
organelles, especially in mitochondrial biogenesis (Sylvestre et al., 2003). In S. 
cerevisiae, half of the transcripts coding for mitochondrial proteins preferentially localize 
to the organelle surface (Sylvestre et al., 2003), and this is also observed in human cells 
(Corral-Debrinski, 2007). There are also reports showing poly-ribosomes transported to a 
specific subcellular localization to translate proteins in close proximity to their final 
localization such as cytoskeleton compartments and neuronal dendrites (Schratt et al., 
2004). The RNA species localized to the mitochondria through AKAP149 binding could 
be released from AKAP149 upon a signal promoting AKAP149 Ser630 
dephosphorylation by a Ser/Thr phosphatase, possibly PP1, making AKAP149 unable to 
associate with RNA (Paper III). Since AKAP149 does not contain a nuclear localization 
signal, the question remains to know how then can AKAP149 enter the nucleus to bind 
RNA? One answer could be that AKAP149 binds a transport molecule which allows 
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AKAP149 to enter the nucleus. It is for instance known that binding to a WW domain 
protein can alter cell localization, as is the case for human NIMA-related kinase 6 
(Nek6). Nek6 usually localize to RNA speckles in the nucleus but mutations in the WW 
binding domain of PPLP result in Nek6 no longer co-localizing to speckles (Lee et al., 
2007a). Also, AKAP149 contains a potential leucine-zipper which can promote nuclear 
import in the absence of a nuclear import signal by binding to other leucine-zipper 
containing proteins (Waldmann et al., 2007). Inside the nucleus, AKAP149 probably 
remains bound to molecules that keep it in the nucleus while binding to RNA, and upon 
release from these factors the seven potential nuclear export signals present in the 
AKAP149 sequence will cause exit from the nucleus. Binding to RNA requires 
AKAP149 to be phosphorylated on Ser630 (Paper III), therefore AKAP149 may be 
phosphorylated by PKA or another kinase on Ser630 in the nucleus, before binding to its 
specific RNA. When AKAP149 re-enters the cytoplasm, RNA can again be transported 
to its proper localization, here mitochondria, where binding is retained until the RNA 
release signal reappears (Fig. 13). 
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Figure 13. Hypothetical model for RNA binding to AKAP149 in the cell. RNA is sandwiched between two 
AKAP149 molecules in the mitochondria, and upon a signal possibly leading to KH domain 
dephosphorylation by PP1, RNA is released from AKAP149 and can be translated. AKAP149 binds a 
transport protein X (X = unknown) which allows AKAP149 entry into the nucleus. In the nucleus 
AKAP149 rebinds RNA after Ser630 phosphorylation of AKAP149, possibly by PKA. Following release 
from the transport protein X, AKAP149 exits the nucleus (AKAP149 contains at least seven potential 
nuclear export signals). The AKAP149-RNA complex is then transported to its proper localization 
depending on AKAP149 NH2-terminal splice-variant and bound RNAs 3’UTR localization sequence, 
which in our example localizes to the mitochondria. (Modified from mac122.icu.ac.jp/gen-ed/eukaryotic-
cell.html) 
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RNA-binding to the KH domain of AKAP149 - QuickRIP 
To determine the nature of RNAs binding AKAP149 in vivo, we optimized an RNA 
immunoprecipitation assay (QuickRIP) for AKAP149, described in Paper IV. 
Immunoprecipitation of AKAP149 was performed after UV-cross-linking and partial 
T1RNAse digestion of the RNA, to obtain RNA fragments with proper length for linker 
ligation, cloning and sequencing. Of note, 85% of the RNAs in a cell are ribosomal, thus 
creating a substantial risk of false positive hits in screening attempts. Even though we 
improved RIP to reduce false positive rRNA hits by the use of magnetic beads, and two 
linker ligations on the beads, it remains difficult to distinguish the real binding to rRNAs 
from false positives. 
 RIP of AKAP149 shows strong enrichment of RNA binding specifically and 
directly to AKAP149. Surprisingly, the identified RNA-binding hits for AKAP149 in 
vivo were solely ribosomal RNAs (Table. 1). None of the mRNAs previously shown to 
bind AKAP149 in vitro were found (Ranganathan et al., 2002; Ginsberg et al., 2003; 
Ranganathan et al., 2005; Dyson et al., 2008). Furthermore, one of the ribosomal (5.8S) 
RNA hits was also found once in the control (Table. 1). Taken together, the rRNA hits 
are interesting, but it remains to be shown whether obtained rRNA are false positives or 
real binding partners of AKAP149.  
 
rRNA Control RIP 
18S 0 1 
5.8S 1 10 
28S 0 8 
 
Table 1. RNA obtained for AKAP149 after UV-cross-linking, immunoprecipitation, cloning and 
identification of the bound eluted RNA by sequencing. Results are identifiable RNA’ obtained from five 
independent RIP experiments. 
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 What would be the implications of AKAP149 really binding ribosomal RNA? It 
has been known for a long time that 5.8S RNA needs to be methylated for protection 
before transport to the mitochondria (Munholland and Nazar, 1987; Abou and Nazar, 
1997). Furthermore, a correlation between level of 5.8S RNA methylation and cellular 
fate has been shown where by reduced ribosomal 5.8S RNA methylation correlates with 
differentiation and development of cancer (Abou et al., 1997). The cell cycle regulator 
and tumor suppressor p53 binds covalently to 5.8S and causes ribosomal stress, aborted 
protein synthesis and p53-dependent cell-cycle arrest (Munholland et al., 1987; Abou et 
al., 1997; Pestov et al., 2001). Dysregulation of p53-induced ribosomal stress is 
correlated with several types of cancers (Gilkes and Chen, 2007). Based on our screen we 
may hypothesize that the KH domain of AKAP149 is involved in protection and transport 
of 5.8S RNA from the nucleus to the mitochondria. Since AKAP149 also contains a 
Tudor domain known to preferentially bind methylated residues, the Tudor domain would 
restrict binding to 5.8S RNA with the proper methylation pattern. To our knowledge, it 
has not been shown that 18S and 28S have methylated RNAs, but it is known that the 
upstream binding factor (UBF) dependent transcription of all ribosomal genes in the 
nucleus by topoisomerase II is significantly affected by the level of ribosomal gene 
methylation (Preuss and Pikaard, 2007). Interestingly we observe in paper II that the KH-
Tudor fragment of AKAP149 localizes in close proximity to UBF in the nucleus of HeLa 
cells, and that UBF co-immunoprecipitates both with the KH-Tudor fragment of 
AKAP149 and with endogenous AKAP149. Taken together, our QuickRIP results may 
suggest a role for AKAP149 in the expression- or post-transcriptional regulation of 
ribosomal RNA in the cell. 
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 One way to solve remaining issues that regards rRNA hits would be to amplify 
immunoprecipitated nucleic acids for hybridization to genome-scale cDNA chips. RIP 
hits should also be supported by other methods like in vitro RNA assays, 
immunofluorescent RNA experiments or PCR with hit-specific primers to be confirmed. 
By analogy to the widely used chromatin immunoprecipitation (ChIP) assay, RIP assays 
can potentially be highly informative provided one resolves the issue of unspecific 
background or false-positive sequencing hits. 
 
RNA deficient mutants of AKAP149 display mitochondrial collapse 
In Paper III we performed mutation analysis to elucidate the features of the KH domain 
of AKAP149, and observed that RNA-binding deficient mutants of AKAP149, when 
transiently-overexpressed in HeLa cells, result in a collapsed mitochondrial phenotype. 
The 1-485 fragment of AKAP149 lacking the KH domain shows the strongest phenotype 
with the mitochondrial network gathered in a compact accumulation on one or both sides 
of the nucleus. Moreover, mitochondria appear as small dots rather than with the 
elongated widely dispersed aspect they present in normal cells. This fragmentation 
suggests a possible involvement for AKAP149 in the mitochondrial fission and fusion 
processes. 
 The mitochondrial network is in a constant equilibrium between mitochondrial 
fission and fusion, where a constant mitochondrial fusion regulated by the mitofusins 
proteins is necessary to prevent the mitochondrial population in the cell from becoming 
highly fragmented (Chen and Chan, 2004). Mitofusins are conserved, large GTPases 
localized to the mitochondrial outer membrane (Santel and Fuller, 2001; Rojo et al., 
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2002; Chen et al., 2003). Mammals have two closely related mitofusin homologues, 
Mfn1 and Mfn2. Cells lacking Mfn1 or Mfn2 have greatly reduced levels of 
mitochondrial fusion (Chen et al., 2003; Chen et al., 2005). In our mutant expression 
assays, mitochondrial collapse phenotype is observed as early as 8 hours after 
transfection. This corresponds to a previous report that shows mitochondrial fusion 
covering the entire mitochondrial network in a human cell within 12 hours, and also that 
blocking of mitofusins or mitofusin-related proteins display mitochondrial fragmentation 
after 4 hours (Legros et al., 2002). Overexpression of Mfn1 or/and Mfn2 has been shown 
to be able to rescue cells with a fragmented mitochondrial phenotype (Santel et al., 2001; 
Chen et al., 2003). Thus, further investigations to elucidate a possible rescue of the 
collapsed mitochondrial phenotype by expression of Mfn1 and/or Mfn2 would be 
required to link this phenotype to a known biological process. 
 Further use of mutants showed that it is the lack of RNA binding to AKAP149 
which leads to a collapsed mitochondrial network. Requirement of correct RNA 
localization for normal cell morphology and viability is a relatively unexplored field. 
However another KH domain-containing protein, Moep19, is suggested to direct RNAs 
essential for normal embryo-development to specific locations in the oocyte and early 
embryo (Herr et al., 2008). Also, mutations in the KH domain of the fragile X mental 
retardation product (FMR1) are correlating with the development of fragile X syndrome, 
especially in the more severe cases. Fragmented or collapsed mitochondrial network has 
often been correlated with loss of mitochondrial membrane potential and apoptosis (Chen 
et al., 2005; Huang et al., 2007) and one intriguing question would be whether loss of 
RNA binding to AKAP149 affects viability? 
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 Although mitochondrial network collapse or fragmentation usually affects 
viability of the cells (Chen et al., 2003;Huang et al., 2007), this is not always the case. 
During the late stages of sperm maturation, a massive mitochondrial compaction is 
shown to be very important for sperm maturation and viability (Cardullo and Baltz, 
1991). In addition, a deletion mutation in the GTPase domain of autosomal dominant 
optic atrophy (OPA1), causes an mitochondrial network collapse and fragmentation, but 
does not seem to increase the level of apoptosis (Spinazzi et al., 2008). Mitochondrial 
network abnormalities caused by OPA1 have been suggested as a cause for autosomal 
dominant optic atrophy – the most common cause of inherited optic atrophy. 
Interestingly, AKAP84, a testis specific, shorter splice variant of the AKAP1(149) gene 
and lacking the KH domain, is kept under strict developmental control in testis. AKAP84 
expression levels increase rapidly during the last steps of sperm maturation as the 
mitochondria gather into the midpiece (Reinton et al., 2000). Strikingly, AKAP149 is 
hardly expressed in testis at all. All together, this leads to the postulate that AKAP84 has 
a role in spermatogenesis that requires the absence of the KH domain. A role for 
AKAP84 in spermatogenesis is conserved from fugu fish to humans (Reinton et al., 
2000), and as previously mentioned so is the RNA binding groove (but not the PP1 
binding RVXF motif), further supporting the idea of the lack of RNA binding to the 
AKAP84 being required for normal testis maturation. In this context it would be 
interesting to over-express full-length AKAP149 in sperm and look for effects on sperm 
maturation. Another question arises from the fact that it is important to keep AKAP84 
under strict control and just expressed in sperm as the mitochondria wanders towards the 
midpiece. Could this open for disease-related studies based upon disrupted mitochondrial 
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network by RNA deficient mutants of AKAP149, perhaps without affecting cell 
viability? This could concern diseases linked to tissues where mitochondria are 
specifically important like brain or muscle (Filosto et al., 2007). 
 
PERSPECTIVES 
It is estimated that 1 person per 8,000 has a disease caused by induced mutations 
affecting mitochondrial function and processes, and mitochondrial dysfunctions are 
currently being implicated in a growing amount of diseases (Tarnopolsky and Raha, 
2005). For instance errors in the mitochondrial fatty acid oxidation causes diseases 
characterized by distinct enzyme or transport deficiencies, leading to liver dysfunction 
and cardiomyopathy, among others (Kompare and Rizzo, 2008). Also, lipid metabolism 
disorders, Parkinsons disease, inherited diabetes mellitus and myopathy are all linked to 
mitochondrial dysfunction (Schocke et al., 2008; Kompare et al., 2008; Gal et al., 2008; 
Mitsui et al., 2008; Bruno and Dimauro, 2008; Vanitallie, 2008). Mitochondria also play 
essential roles in natural aging, viral infection and metabolism – all areas where 
AKAP149 potentially could play important roles. The impact AKAP149 exerts on 
mitochondrial functions and cell viability remains to be demonstrated, and can potentially 
link AKAP149 to one or more mitochondrial dysfunction caused disease in the future.  
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